Loading…
National Commission on Scleroderma and Fibrotic Diseases Act of 2019
Legislative Progress
Introduced
September 12, 2019
Latest Action
September 12, 2019
Primary Sponsor
Kirsten E. GillibrandDemocratic(NY)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
National Commission on Scleroderma and Fibrotic Diseases Act of 2019 This bill temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2020 · fourth_quarter · Health Issues
Scleroderma & Fibrosis Research 21st Century Cures Implementation Healthcare Reform, Patient Protections COVID-19 Relief Packages HR 3446 S.2477 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2020 · third_quarter · Health Issues
Scleroderma & Fibrosis Research 21st Century Cures Implementation Healthcare Reform, Patient Protections COVID-19 Relief Packages HR 3446 S.2477 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2020 · second_quarter · Health Issues
Scleroderma & Fibrosis Research 21st Century Cures Implementation Healthcare Reform, Patient Protections COVID-19 Relief Packages HR 3446 S.2477 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2020 · first_quarter · Health Issues
Scleroderma & Fibrosis Research 21st Century Cures Implementation Healthcare Reform, Patient Protections COVID-19 Relief Packages HR 3446 S.2477 CDC Chronic Disease Education and Awareness COVID-19 Relief Packages
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2020 · first_quarter · Health Issues
Scleroderma & Fibrosis Research 21st Century Cures Implementation Healthcare Reform, Patient Protections COVID-19 Relief Packages HR 3446 S.2477 CDC Chronic Disease Education and Awareness
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
| Democratic |
| MI |
| Susan M. Collins | Republican | ME |